Firstly, we treated the three prostate cancer cell lines with 10 μmol/L of DNA demethylation agent 5-Aza-2′-deoxycytidine (5-Aza-DC), and detected the expression level of TGFBR2 by RT-PCR. Here, TGFBR2 is linked to prostate carcinoma.